|
Market Closed -
Nasdaq
16:00:00 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 4.660 USD | -2.10% |
|
-6.99% | +63.51% |
| 08-31 | Lifeward Names Josh Hexter as Interim CEO and Rami Aviram as CFO | MT |
| 08-10 | Oramed Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Stock exchange
Nasdaq
ORMP 4.660 $
-2.10%
674K
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| ORMP | 4.660USD | -2.10% | 674K $ | ||
Börse Stuttgart
| OJU1 | 3.985EUR | -2.21% | 19.92K € | |
|
CBOE
| ORMP | 4.670USD | -2.10% | 16.91K $ | |
|
TEL AVIV STOCK EXCHANGE
| ORMP | 1,425.00ILa | -2.40% | 654K ILa | |
|
Deutsche Boerse AG
| OJU1 | 4.045EUR | -0.25% | 0 € | |
|
Tradegate
| OJU1 | 4.020EUR | -2.07% | 0 € | |
|
Boerse Muenchen
| OJU1 | 4.050EUR | -2.17% | 0 € |
Quotes 5-day view: Oramed Pharmaceuticals Inc.
Delayed Quote Nasdaq
| 2026-09-04 | 2026-09-08 | 2026-09-09 | 2026-09-10 | 2026-09-11 | |
|---|---|---|---|---|---|
| Last | US$5.010 | US$4.980 | US$4.780 | US$4.760 | US$4.660 |
| Volume | 226,873 | 118,174 | 245,685 | 131,469 | 144,534 |
| Change | +1.62% | -0.60% | -4.02% | -0.42% | -2.10% |
| Opening | US$4.920 | US$4.990 | US$4.940 | US$4.740 | US$4.810 |
| High | US$5.050 | US$5.010 | US$4.940 | US$4.854 | US$4.820 |
| Low | US$4.860 | US$4.920 | US$4.700 | US$4.660 | US$4.650 |
Performance
| 1 day | -2.10% | ||
| 1 week | -6.99% | ||
| Current month | -7.17% | ||
| 1 month | +9.65% | ||
| 3 months | +22.63% | ||
| 6 months | +37.06% | ||
| Current year | +63.51% | ||
| 1 year | +91.77% | ||
| 3 years | +53.29% | ||
| 5 years | -76.11% | ||
| 10 years | -37.37% |
Volumes
marketsDaily volume
144,534
Estimated daily volume
144,534
Avg. Volume 20 sessions
234,960
Daily volume ratio
0.62
Avg. Volume 20 sessions USD
1,094,913.6
Record volume 1
28,551,520
Record volume 2
24,841,760
Record volume 3
17,091,290
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
193,843,669
Net sales (USD)
2,000,000
Number of employees
4
Sales / Employee (USD)
500,000
Free-Float
82.35 %
Free-Float capitalization (USD)
159,630,974
Average Daily Capital Traded
0.56%
Indicators
Moving average 5 days
4.838
Moving average 20 days
4.875
Moving average 50 days
4.47
Moving average 100 days
4.277
Price spread / (MMA5)
+3.82%
Price spread / (MMA20)
+4.61%
Price spread / (MMA50)
-4.08%
Price spread / (MMA100)
-8.22%
RSI 9 days
44.83
RSI 14 days
50.42
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.10% | -6.99% | +91.77% | +53.29% | 194M | |
| -0.71% | -6.35% | -4.87% | +9.03% | 45.48B | |
| +0.21% | -2.98% | +340.68% | +519.93% | 43.69B | |
| +1.74% | -2.24% | +37.28% | +21.57% | 43.09B | |
| +1.38% | -3.28% | +3.23% | +65.60% | 39.4B | |
| -1.44% | -5.26% | +8.78% | +36.85% | 31.91B | |
| +0.87% | -2.60% | - | - | 17.31B | |
| +0.75% | -0.64% | +18.07% | +110.32% | 16.4B | |
| -0.31% | -2.78% | +10.47% | +30.49% | 14.24B | |
| +1.93% | -3.55% | +74.20% | +39.37% | 13.28B | |
| Average | +0.23% | -3.92% | +64.40% | +98.49% | 26.5B | |
| Weighted average by Cap. | +0.41% | -3.67% | +73.18% | +123.51% |
Historical Quotes: Oramed Pharmaceuticals Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
4a0a9d0bca6a7e.rd9U4wR9usyQXXMLjSj9RCsqNmbZbIZxFnt9iBtCbdM.wZk4qFFMyfnXFEYm3mDLCWceaSy2CLUpXy0u20EYL4LKkTHbMAjzj8E5Qw
| Date | Price | Volume | Total |
|---|---|---|---|
| 16:00:00 | 4.660 | 11,609 | 115,891 |
| 15:59:56 | 4.660 | 113 | 104,282 |
| 15:59:56 | 4.660 | 133 | 104,169 |
| 15:59:56 | 4.660 | 200 | 104,036 |
| 15:59:56 | 4.665 | 200 | 103,836 |
| 15:59:56 | 4.670 | 169 | 103,636 |
| 15:59:56 | 4.670 | 169 | 103,467 |
| 15:59:56 | 4.660 | 200 | 103,298 |
| 15:59:56 | 4.650 | 878 | 103,098 |
| 15:59:56 | 4.650 | 100 | 102,220 |
Price Extremes
| 1 week | 4.65 |  | 5.01 |
| 1 month | 4.3 | | 5.47 |
| Current year | 2.83 | | 5.47 |
| 1 year | 2.09 | | 5.47 |
| 3 years | 1.67 | | 5.47 |
| 5 years | 1.67 | | 31.54 |
| 10 years | 1.67 | | 31.54 |
Monthly variations
Annual variations
| 2026 | +63.51% | ||
| 2025 | +17.77% | ||
| 2024 | +4.76% | ||
| 2023 | -80.80% | ||
| 2022 | -15.76% | ||
| 2021 | +236.79% | ||
| 2020 | -17.67% | ||
| 2019 | +71.67% | ||
| 2018 | -66.67% | ||
| 2017 | +47.06% | ||
| 2016 | -28.42% | ||
| 2015 | +87.50% | ||
| 2014 | -70.45% | ||
| 2013 | +289.64% | ||
| 2012 | +17.86% | ||
| 2011 | -6.67% | ||
| 2010 | -33.33% | ||
| 2009 | +15.38% | ||
| 2008 | +50.00% | ||
| 2007 | -69.05% | ||
| 2006 | +170.97% | ||
| 2005 | +24.00% | ||
| 2004 | +1,549.94% |
- Stock Market
- Stocks
- ORMP Stock
- Quotes Oramed Pharmaceuticals Inc.
Select your edition
All financial news and data tailored to specific country editions
